Wuhan General Hospital
Wuhan, Hubei, 430070, China
NCT Number: NCT01556984
Endothelial dysfunction is the early step of atherosclerosis. Therefore, the investigators hypothesize that digital subtraction angiography (DSA) can damage endothelial function. In this study, the investigators will select 200 diabetic patients who have a DSA for diabetic foot screening. Also, the investigators will select 100 healthy subjects as controls. The endothelial function will be determined by high resolution ultrasound before and after DSA. The investigators will observe the changes of endothelial function after DSA assay.
Looking for future studies?
Notify Me40 year–70 year
All sexes
Observational
Wuhan, Hubei, 430070, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All patients with diabetic foot perform a DSA assay. Before and after DSA, endothelial function will be measured.
Time frame: 10 months
Wuhan General Hospital of Guangzhou Military Command
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05189470
Cardiovascular Diseases, Diabetes
Herlev, Denmark
View Trial DetailsNCT07270328
Behavior, Cardiovascular Diseases
Sleman, Special Region of Yogyakarta, Indonesia
View Trial DetailsNCT06518486
Cardiovascular Diseases, Diabetes
Batang, Central Java, Indonesia
View Trial DetailsNCT06250049
Cardiovascular Diseases, Diabetes
Salamanca, Spain
View Trial Details